Side Effect Of 5-Hydroxytriptamine Receptor Antagonist In The Prophylactic Treatment Of Emesis Induced By Cisplatin And Taxotere Chemotherapy A Case Report.
The 5-hydroxytryptamine3 receptor (5-HT3receptor) antagonists recently has been developed as a class of new anti-emetic agent.
| Main Authors: | Djunaedi, Mochamad, Mohd Yussof, Zuraidah, Othman, Saad |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
2006
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/2020/ http://eprints.usm.my/2020/1/Side_Effect_Of_5-Hydroxytriptamine_Receptor_Antagonist_In_The_Prophylactic_Treatment_Of_Emesis_Induced_By_Cisplatin_And_Taxotere_Chemotherapy_A_Case_Report.pdf |
Similar Items
Vestibulotoxicity and balance problems associated with cisplatin chemotherapy in adult cancer survivors
by: Prayuenyong, Pattarawadee
Published: (2021)
by: Prayuenyong, Pattarawadee
Published: (2021)
The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals
by: Mochamad Djunaedi, Mochamad Djunaedi
Published: (2016)
by: Mochamad Djunaedi, Mochamad Djunaedi
Published: (2016)
Estimating Gfr In Oncology Patients Receiving Cisplatin Chemotherapy : Predicted Creatinine Clearance Against Tc-99m Dtpa Methods
by: Syed Sahab, Sharifah Khaidah
Published: (2016)
by: Syed Sahab, Sharifah Khaidah
Published: (2016)
Prophylactic antibiotics for the prevention of cellulitis
by: Thomas, K.S.
Published: (2007)
by: Thomas, K.S.
Published: (2007)
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
by: Valle, Juan W., et al.
Published: (2015)
by: Valle, Juan W., et al.
Published: (2015)
QSAR study of platelet-activating factor (PAF) receptor binding antagonist
by: Abdullah, Nor Hayati, et al.
Published: (2013)
by: Abdullah, Nor Hayati, et al.
Published: (2013)
Cubyl amides: Novel P2X7 receptor antagonists
by: Gunosewoyo, Hendra, et al.
Published: (2008)
by: Gunosewoyo, Hendra, et al.
Published: (2008)
Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy
by: Sun, H., et al.
Published: (2016)
by: Sun, H., et al.
Published: (2016)
Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
by: Baselga, J., et al.
Published: (2013)
by: Baselga, J., et al.
Published: (2013)
Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells
by: Seah, S., et al.
Published: (2015)
by: Seah, S., et al.
Published: (2015)
QSAR study of flavonoids as platelet-activating factor (PAF) receptor binding antagonists
by: Abdullah, Nor Hayati, et al.
Published: (2014)
by: Abdullah, Nor Hayati, et al.
Published: (2014)
Attenuation of cisplatin-induced hepatotoxicity in rats using zerumbone.
by: Ibrahim, Mohammed Yousif, et al.
Published: (2009)
by: Ibrahim, Mohammed Yousif, et al.
Published: (2009)
Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)
by: Smyth, Alan R., et al.
Published: (2014)
Purinergic P2X7 Receptor Antagonists: Chemistry and Fundamentals of Biological Screening
by: Gunosewoyo, Hendra, et al.
Published: (2009)
by: Gunosewoyo, Hendra, et al.
Published: (2009)
Identification of novel competitive antagonists for Histamine H1 receptor in Malaysian kelulut honey
by: Feng, Tan wei, et al.
Published: (2025)
by: Feng, Tan wei, et al.
Published: (2025)
Naturally-occurring glucosinolates, glucoraphanin and glucoerucin, are antagonists to aryl hydrocarbon receptor as their chemopreventive potency
by: Abdull Razis, Ahmad Faizal, et al.
Published: (2015)
by: Abdull Razis, Ahmad Faizal, et al.
Published: (2015)
Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting
by: Lancaster, C., et al.
Published: (2010)
by: Lancaster, C., et al.
Published: (2010)
The effects of cisplatin on developing nociceptive pathways
by: Lloyd, Joseph
Published: (2017)
by: Lloyd, Joseph
Published: (2017)
Drug-like antagonists of P2Y receptors — from lead identification to drug development
by: Conroy, Sean, et al.
Published: (2016)
by: Conroy, Sean, et al.
Published: (2016)
Discovery of AZD-2098 and AZD-1678, two potent and bioavailable CCR4 receptor antagonists
by: Kindon, Nicholas, et al.
Published: (2017)
by: Kindon, Nicholas, et al.
Published: (2017)
Design, Synthesis, and Evaluation of New P2Y2 Receptor Antagonists and Fluorescent Ligands
by: Knight, Rebecca
Published: (2025)
by: Knight, Rebecca
Published: (2025)
Prophylactic Antibiotic Use in Breast Cancer Surgery Patients
by: Habak, Jawad, et al.
Published: (2013)
by: Habak, Jawad, et al.
Published: (2013)
Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism
by: Corriden, Ross, et al.
Published: (2014)
by: Corriden, Ross, et al.
Published: (2014)
Development of novel fluorescent histamine H₁-receptor
antagonists to study ligand-binding kinetics in living cells
by: Stoddart, Leigh A., et al.
Published: (2018)
by: Stoddart, Leigh A., et al.
Published: (2018)
Metal-based antitumor compounds: beyond cisplatin
by: Simpson, Peter, et al.
Published: (2019)
by: Simpson, Peter, et al.
Published: (2019)
Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches
by: Shu, Yih Chew, et al.
Published: (2016)
by: Shu, Yih Chew, et al.
Published: (2016)
P2Y purinergic receptor signaling in oral squamous cell carcinoma cell lines and its role in proliferation and cisplatin-mediated apoptosis
by: Lok, Mun Law, et al.
Published: (2022)
by: Lok, Mun Law, et al.
Published: (2022)
Discovery of fevipiprant (NVP-QAW039), a potent and selective DP2 receptor antagonist for treatment of asthma
by: Sandham, David A., et al.
Published: (2017)
by: Sandham, David A., et al.
Published: (2017)
The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
by: Wilkinson, S., et al.
Published: (2014)
by: Wilkinson, S., et al.
Published: (2014)
Use of complementary and alternative medicine in management of chemotherapy related side effects among cancer patients / Sharifah Nadia Syed Mohammad Salleh
by: Syed Mohammad Salleh, Sharifah Nadia
Published: (2017)
by: Syed Mohammad Salleh, Sharifah Nadia
Published: (2017)
Cisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A
by: Vencappa, Samanta, et al.
Published: (2015)
by: Vencappa, Samanta, et al.
Published: (2015)
Prophylactic effects of Clausena excavata Burum. f. leaf extract in ethanol-induced gastric ulcers
by: Albaayit, Shaymaa Fadhel Abbas, et al.
Published: (2016)
by: Albaayit, Shaymaa Fadhel Abbas, et al.
Published: (2016)
Prophylactic effect of edible bird's nest on acetaminophen-induced liver injury response in mice model
by: Muhammad-Azam, Fazil, et al.
Published: (2022)
by: Muhammad-Azam, Fazil, et al.
Published: (2022)
Influences on decision-making for young women undergoing bilateral prophylactic mastectomy
by: Glassey, R., et al.
Published: (2017)
by: Glassey, R., et al.
Published: (2017)
Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics
by: Huckle, Anthony W., et al.
Published: (2018)
by: Huckle, Anthony W., et al.
Published: (2018)
Cancer incidence and chemotherapy-induced adverse effects in Asia
by: Khatab, Nasir Ibrahim Omar, et al.
Published: (2019)
by: Khatab, Nasir Ibrahim Omar, et al.
Published: (2019)
Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors
by: Sykes, David A., et al.
Published: (2017)
by: Sykes, David A., et al.
Published: (2017)
A sensitive and reliable RP-HPLC method for the detection of cimetidine - a H2 receptor antagonist in human plasma
by: Helal Uddin, A.B.M., et al.
Published: (2019)
by: Helal Uddin, A.B.M., et al.
Published: (2019)
Synthesis and evaluation of the first fluorescent antagonists of the human P2Y2 receptor based on AR-C118925
by: Conroy, Sean, et al.
Published: (2018)
by: Conroy, Sean, et al.
Published: (2018)
Expression of complement C5a receptor and the viability of 4T1 tumor cells following agonist–antagonist treatment
by: Kosni, Nurneqman Nashreq, et al.
Published: (2016)
by: Kosni, Nurneqman Nashreq, et al.
Published: (2016)
Similar Items
-
Vestibulotoxicity and balance problems associated with cisplatin chemotherapy in adult cancer survivors
by: Prayuenyong, Pattarawadee
Published: (2021) -
The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals
by: Mochamad Djunaedi, Mochamad Djunaedi
Published: (2016) -
Estimating Gfr In Oncology Patients Receiving Cisplatin Chemotherapy : Predicted Creatinine Clearance Against Tc-99m Dtpa Methods
by: Syed Sahab, Sharifah Khaidah
Published: (2016) -
Prophylactic antibiotics for the prevention of cellulitis
by: Thomas, K.S.
Published: (2007) -
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
by: Valle, Juan W., et al.
Published: (2015)